New MRI Technique Simultaneously Measures Cerebral Blood Flow and Blood Oxygenation Levels for Studying Alzheimer’s Disease
By MedImaging International staff writers Posted on 15 Feb 2022 |
To better understand early stages of Alzheimer's, investigators will use a new magnetic resonance imaging (MRI) technique developed by Deqiang Qiu’s lab that simultaneously measures cerebral blood flow and blood oxygenation levels.
Scientists at Emory University (Atlanta, GA, USA) will investigate how problems in blood flow, known as cerebrovascular impairment, contribute to the early phases of Alzheimer’s. The goal of the project is to study how Alzheimer’s pathology interacts with cerebrovascular impairment in the early phases of the disease, as well as the relative contributions of cerebrovascular and Alzheimer’s pathologies to cognitive impairment.
In the planned study, investigators will use a new MRI technique that simultaneously measures cerebral blood flow and blood oxygenation levels. The technique involves temporarily exposing someone to air with normal levels of oxygen and slightly elevated levels of carbon dioxide. The MRI-based approach will be combined with positron emission tomography (PET) to image the deposition of amyloid plaques in the brain, a characteristic pathology seen in Alzheimer’s that also can appear in healthy individuals.
The study will include healthy younger and elderly participants, people who are asymptomatic but display amyloid plaques via PET imaging, as well as people who are considered to have a prodromal stage of Alzheimer’s because they have mild cognitive impairment and signs of Alzheimer’s pathology. The project could eventually lead to the development of effective multi-component therapeutic interventions that target both AD and vascular pathologies.
Speaking about the technique, Deqiang Qiu, PhD, who is associate professor of radiology and imaging sciences at Emory, said, “This will increase the blood flow and oxygenation level in a normal brain, termed cerebrovascular reactivity or CVR. “However, CVR is impaired in aging and more severely impaired in Alzheimer’s disease.”
Related Links:
Emory University
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer